Back to Search
Start Over
Supplementary Methods from Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Detailed description of methods used in this study.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....11b2f9c28ce9fd61d5a4c60b91ae88c2
- Full Text :
- https://doi.org/10.1158/1535-7163.22502103.v1